Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLoans and Notes ReceivablesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Loans and Notes Receivables (2025)

Lifecore Biomedical, Inc. \De\ has reported Loans and Notes Receivables over the past 3 years, most recently at $8.0 million for Q2 2025.

  • Quarterly results put Loans and Notes Receivables at $8.0 million for Q2 2025, changed N/A from a year ago — trailing twelve months through May 2025 was $8.0 million (changed N/A YoY), and the annual figure for FY2025 was $8.0 million, changed.
  • Loans and Notes Receivables for Q2 2025 was $8.0 million at Lifecore Biomedical, Inc. \De\, roughly flat from $8.0 million in the prior quarter.
  • Over the last five years, Loans and Notes Receivables for LFCR hit a ceiling of $8.0 million in Q1 2025 and a floor of $8.0 million in Q1 2025.